Atomic AI, which uses machine learning to explore the potential of RNA in drug discovery, raised a $35 million series A round.
They have developed a machine learning model that can accurately predict the structure of RNA molecules based on a limited set of data.
They have since improved their model and are using it to pursue their own drug discovery program, which produces candidate molecules that might work to treat conditions that are drug resistant or notoriously difficult to treat.
Having written the articles, I think they’re pretty solid summaries, but brief enough that they (hopefully) pique your interest. …
Read more…….
